ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injury

Ira Wong1, Hong Liao, Xianshu Bai

  • 1Department of Human Physiology and Centre for Neuroscience, Flinders University, GPO Box 2100, Adelaide, SA 5001, Australia.

Insights

Pro-brain-derived neurotrophic factor (proBDNF) hinders macrophage infiltration after spinal cord injury. Blocking proBDNF enhances immune cell migration and improves functional recovery, suggesting a detrimental role in CNS injury.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Central nervous system (CNS) regeneration is limited by slow myelin debris clearance after injury.
  • The precise mechanisms controlling this inefficient clearance remain unclear.

Purpose of the Study:

  • To investigate the role of endogenous pro-brain-derived neurotrophic factor (proBDNF) in regulating inflammatory cell infiltration following spinal cord injury (SCI).
  • To determine if proBDNF influences macrophage migration and impacts functional recovery after SCI.

Main Methods:

  • Western blots and immunocytochemistry to detect proBDNF and its receptors (sortilin, p75NTR) post-SCI.
  • In vitro studies assessing macrophage migration in response to proBDNF and anti-proBDNF antibodies.
  • In vivo administration of anti-proBDNF antiserum after SCI in a mouse model.
  • Behavioral assessment using BBB (Basso, Beattie, Bresnahan) tests for functional recovery.

Main Results:

  • ProBDNF and its receptors (sortilin, p75NTR) were expressed in the spinal cord after injury.
  • Macrophages (ED1+ in vivo, CD11b+ in vitro) expressed proBDNF, sortilin, and p75NTR.
  • ProBDNF suppressed macrophage migration in vitro; anti-proBDNF antibody enhanced it.
  • In vivo administration of anti-proBDNF antibody increased macrophage infiltration and neuron survival.
  • Functional recovery, assessed by BBB tests, was improved following anti-proBDNF treatment.

Conclusions:

  • Endogenous proBDNF acts as a suppressor of macrophage migration and infiltration into the injured spinal cord.
  • Targeting proBDNF with antibodies may represent a therapeutic strategy to enhance immune cell infiltration and promote functional recovery after SCI.
  • ProBDNF appears to play a detrimental role in the context of spinal cord injury and myelin debris clearance.

Related Concept Videos